Twist Promotes Reprogramming of Glucose Metabolism in Breast Cancer Cells Through PI3K/AKT and P53 Signaling Pathways

Overview

Journal Oncotarget

Specialty Oncology

Date 2015 Sep 6

PMID 26342198

Citations 59

Authors

Li Yang

Yixuan Hou

Jie Yuan

Shifu Tang

Hailong Zhang

Qing Zhu

Yan-E Du

Mingli Zhou

Siyang Wen

Liyun Xu

Xi Tang

Xiaojiang Cui

Manran Liu

Affiliations

Soon will be listed here.

Abstract

Twist, a key regulator of epithelial-mesenchymal transition (EMT), plays an important role in the development of a tumorigenic phenotype. Energy metabolism reprogramming (EMR), a newly discovered hallmark of cancer cells, potentiates cancer cell proliferation, survival, and invasion. Currently little is known about the effects of Twist on tumor EMR. In this study, we found that glucose consumption and lactate production were increased and mitochondrial mass was decreased in Twist-overexpressing MCF10A mammary epithelial cells compared with vector-expressing MCF10A cells. Moreover, these Twist-induced phenotypic changes were augmented by hypoxia. The expression of some glucose metabolism-related genes such as PKM2, LDHA, and G6PD was also found to be upregulated. Mechanistically, activated β1-integrin/FAK/PI3K/AKT/mTOR and suppressed P53 signaling were responsible for the observed EMR. Knockdown of Twist reversed the effects of Twist on EMR in Twist-overexpressing MCF10A cells and Twist-positive breast cancer cells. Furthermore, blockage of the β1-integrin/FAK/PI3K/AKT/mTOR pathway by siRNA or specific chemical inhibitors, or rescue of p53 activation can partially reverse the switch of glucose metabolism and inhibit the migration of Twist-overexpressing MCF10A cells and Twist-positive breast cancer cells. Thus, our data suggest that Twist promotes reprogramming of glucose metabolism in MCF10A-Twist cells and Twist-positive breast cancer cells via activation of the β1-integrin/FAK/PI3K/AKT/mTOR pathway and inhibition of the p53 pathway. Our study provides new insight into EMR.

Citing Articles

TWIST1 regulates HK2 ubiquitination degradation to promote pancreatic cancer invasion and metastasis.

Wang X, Ma M, Shao S, Xu X, Qin C, Gao R Cancer Cell Int. 2025; 25(1):37.

PMID: 39920765 PMC: 11806722. DOI: 10.1186/s12935-024-03583-z.

Twist-Induced Epithelial-to-Mesenchymal Transition Confers Specific Metabolic and Mitochondrial Alterations.

Parker H, Haberman K, Ojo T, Watkins J, Nambiar A, Morales K Cells. 2025; 14(2).

PMID: 39851508 PMC: 11763985. DOI: 10.3390/cells14020080.

The Multifaced Role of Collagen in Cancer Development and Progression.

Lo Buglio G, Lo Cicero A, Campora S, Ghersi G Int J Mol Sci. 2025; 25(24.

PMID: 39769286 PMC: 11678882. DOI: 10.3390/ijms252413523.

Integrin β1 in breast cancer: mechanisms of progression and therapy.

Huang Q, Wang J, Ning H, Liu W, Han X Breast Cancer. 2024; 32(1):43-59.

PMID: 39343856 DOI: 10.1007/s12282-024-01635-w.

Glycolysis Reprogramming in Idiopathic Pulmonary Fibrosis: Unveiling the Mystery of Lactate in the Lung.

Yan P, Liu J, Li Z, Wang J, Zhu Z, Wang L Int J Mol Sci. 2024; 25(1).

PMID: 38203486 PMC: 10779333. DOI: 10.3390/ijms25010315.

References

Carraway H, Hidalgo M . New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists. Breast Cancer Res. 2004; 6(5):219-24. PMC: 549184. DOI: 10.1186/bcr927. View

Warburg O . On the origin of cancer cells. Science. 1956; 123(3191):309-14. DOI: 10.1126/science.123.3191.309. View

Lim S, Mikolon D, Stupack D, Schlaepfer D . FERM control of FAK function: implications for cancer therapy. Cell Cycle. 2008; 7(15):2306-14. PMC: 2574722. DOI: 10.4161/cc.6367. View

Gatenby R, Gillies R . Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004; 4(11):891-9. DOI: 10.1038/nrc1478. View

Sheng S, Liu J, Dai Y, Sun X, Xiong X, Huang G . Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma. FEBS J. 2012; 279(20):3898-910. DOI: 10.1111/j.1742-4658.2012.08748.x. View

Piccinin S, Tonin E, Sessa S, Demontis S, Rossi S, Pecciarini L . A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation. Cancer Cell. 2012; 22(3):404-15. DOI: 10.1016/j.ccr.2012.08.003. View

Gottlieb E, Vousden K . p53 regulation of metabolic pathways. Cold Spring Harb Perspect Biol. 2010; 2(4):a001040. PMC: 2845207. DOI: 10.1101/cshperspect.a001040. View

Sun Q, Chen X, Ma J, Peng H, Wang F, Zha X . Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc Natl Acad Sci U S A. 2011; 108(10):4129-34. PMC: 3054028. DOI: 10.1073/pnas.1014769108. View

Xie H, Valera V, Merino M, Amato A, Signoretti S, Linehan W . LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer. Mol Cancer Ther. 2009; 8(3):626-35. PMC: 2671637. DOI: 10.1158/1535-7163.MCT-08-1049. View

10.

Eckert M, Lwin T, Chang A, Kim J, Danis E, Ohno-Machado L . Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell. 2011; 19(3):372-86. PMC: 3072410. DOI: 10.1016/j.ccr.2011.01.036. View

11.

Zhao Y, Zhou M, Liu H, Ding Y, Khong H, Yu D . Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene. 2009; 28(42):3689-701. DOI: 10.1038/onc.2009.229. View

12.

Brooks Robey R, Hay N . Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol. 2009; 19(1):25-31. PMC: 2814453. DOI: 10.1016/j.semcancer.2008.11.010. View

13.

Dang C . Links between metabolism and cancer. Genes Dev. 2012; 26(9):877-90. PMC: 3347786. DOI: 10.1101/gad.189365.112. View

14.

Wood T . Physiological functions of the pentose phosphate pathway. Cell Biochem Funct. 1986; 4(4):241-7. DOI: 10.1002/cbf.290040403. View

15.

Yang J, Mani S, Liu Donaher J, Ramaswamy S, Itzykson R, Come C . Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 2004; 117(7):927-39. DOI: 10.1016/j.cell.2004.06.006. View

16.

Mazurek S . Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol. 2010; 43(7):969-80. DOI: 10.1016/j.biocel.2010.02.005. View

17.

Christofk H, Vander Heiden M, Harris M, Ramanathan A, Gerszten R, Wei R . The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008; 452(7184):230-3. DOI: 10.1038/nature06734. View

18.

Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E . The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004; 64(7):2627-33. DOI: 10.1158/0008-5472.can-03-0846. View

19.

Merlo G, Basolo F, Fiore L, Duboc L, Hynes N . p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J Cell Biol. 1995; 128(6):1185-96. PMC: 2120420. DOI: 10.1083/jcb.128.6.1185. View

20.

Ferreira L . Cancer metabolism: the Warburg effect today. Exp Mol Pathol. 2010; 89(3):372-80. DOI: 10.1016/j.yexmp.2010.08.006. View